EUVIMEDEUVIMED entdecken
Multizentrische StudieValidierungsstudieOpen Access · CC BY 4.0

PSC ‐ DM : A Validated Clinical Diagnostic Model for Distinguishing Primary From Secondary Sclerosing Cholangitis

Miki Scaravaglio iD, Rodrigo V Motta iD, Laura Cristoferi iD, Cesare Maino iD, Alberto Marini, Eugenia Nofit, Eugenia Pesatori, Camilla Gallo iD, Francesca Bolis iD, Daphne D'Amato iD, Armando Curto iD, Federica Malinverno und 9 weitere

Liver International · 2026-11 · 46 (11)

DOI: 10.1111/liv.70892 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Liver International, online erschienen am 30.09.2026. Verfasst von Miki Scaravaglio und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy. Hauptthemen laut MEDLINE: Cholangitis, Sclerosing. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Primary sclerosing cholangitis (PSC) is a rare, progressive cholangiopathy for which diagnosis remains challenging because of the absence of disease‐specific markers and the presence of secondary causes of sclerosing cholangitis (SSC) that closely mimic its clinical presentation. Diagnostic uncertainty can delay appropriate management and add to the psychological burden experienced by patients. This study aimed to identify clinical parameters that support the early and accurate differentiation of PSC from SSC.

Methods

We conducted a multicentre retrospective study of adults with an established diagnosis of PSC or SSC. Independent predictors of PSC were identified using multivariable logistic regression and externally validated in an independent cohort.

Results

In the derivation cohort ( n = 234, 155 PSC, 79 SSC), six variables were independently associated with PSC diagnosis, including younger age at presentation ( p < 0.0001), presence of IBD ( p < 0.0001), absence of prior hepato‐pancreato‐biliary surgery ( p < 0.0001), autoimmune comorbidities ( p = 0.0038), family history of autoimmune diseases ( p = 0.0086), and absence of pancreatic abnormalities ( p = 0.0338). These variables were used to develop the PSC diagnostic model (PSC‐DM). In the external validation cohort ( n = 142, 98 PSC, 44 SSC), the AUROC of PSC‐DM was 0.95 (95% CI 0.91–0.98). In an exploratory analysis, PSC‐DM significantly improved non‐expert diagnostic accuracy (94.3% versus 78.6%, p = 0.0023).

Conclusions

PSC‐DM is a simple, externally validated clinical prediction model that accurately distinguishes PSC from SSC using routinely available clinical variables. It may support initial diagnostic assessment in non‐specialist settings, facilitate timely referral to expert centres and improve patient selection for clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholangitis, SclerosingHumansRetrospective StudiesFemaleDiagnosis, DifferentialMiddle AgedAdultMaleLogistic ModelsInflammatory Bowel DiseasesMultivariate Analysis

Stichwörter der Autor:innen

autoimmunedifferential diagnosisinflammatory bowel diseaseprimary sclerosing cholangitissecondary sclerosing cholangitis

Autor:innen und Institutionen

  • Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
  • Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
  • Translational Gastroenterology and Liver Unit, John Radcliffe Hospital, and Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Division of Gastroenterology, Center for Autoimmune Liver Diseases, IRCCS Fondazione San Gerardo Dei Tintori, ERN-RARE LIVER - Monza, Monza, Italy.
  • Department of Diagnostic Radiology, Fondazione IRCCS San Gerardo Dei Tintori, Monza, Italy.
  • Hepatology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.

ORCID-Profile: Miki Scaravaglio, Rodrigo V Motta, Laura Cristoferi, Cesare Maino, Camilla Gallo, Francesca Bolis, Daphne D'Amato, Armando Curto, Alessio Gerussi, Stephen J Rossi, Kris V Kowdley, Pietro Invernizzi, Marco Carbone, Emma L Culver

Zitieren

APA

Scaravaglio, M., Motta, R. V., Cristoferi, L., Maino, C., Marini, A., Nofit, E., Pesatori, E., Gallo, C., Bolis, F., D'Amato, D., Curto, A., Malinverno, F., Gerussi, A., Viganò, R., Viganò, M., Rossi, S. J., Kowdley, K. V., Invernizzi, P., Nardi, A., …, & Culver, E. L. (2026). PSC ‐ DM : A Validated Clinical Diagnostic Model for Distinguishing Primary From Secondary Sclerosing Cholangitis. Liver International, 46(11). https://doi.org/10.1111/liv.70892

Vancouver

Scaravaglio M, Motta RV, Cristoferi L, Maino C, Marini A, Nofit E, et al. PSC ‐ DM : A Validated Clinical Diagnostic Model for Distinguishing Primary From Secondary Sclerosing Cholangitis. Liver International. 2026;46(11). doi:10.1111/liv.70892

BibTeX
@article{Scaravaglio2026,
  author = {Scaravaglio, Miki and Motta, Rodrigo V and Cristoferi, Laura and Maino, Cesare and Marini, Alberto and Nofit, Eugenia and Pesatori, Eugenia and Gallo, Camilla and Bolis, Francesca and D'Amato, Daphne and Curto, Armando and Malinverno, Federica and Gerussi, Alessio and Viganò, Raffaella and Viganò, Mauro and Rossi, Stephen J and Kowdley, Kris V and Invernizzi, Pietro and Nardi, Alessandra and Carbone, Marco and Culver, Emma L},
  title = {PSC ‐ DM : A Validated Clinical Diagnostic Model for Distinguishing Primary From Secondary Sclerosing Cholangitis},
  journal = {Liver International},
  year = {2026},
  volume = {46},
  number = {11},
  doi = {10.1111/liv.70892}
}
Kostenlos starten →